PRIA Logo™
DelawareSB 320153rd General Assembly (2024–2026)Senate

AN ACT TO AMEND TITLE 16 AND TITLE 24 OF THE DELAWARE CODE RELATING TO PHARMACY AND PHARMACISTS.

Sponsored By: Marie Pinkney (Democratic)

Signed by Governor

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

More pharmacy prescriptions and medicine testing

The law lets licensed Delaware pharmacists prescribe over-the-counter products, opioid overdose reversal medicines, and medicines covered by collaborative practice agreements. Pharmacists can also prescribe FDA-labeled, non-controlled medicines and devices for qualifying conditions. Those conditions must need no new diagnosis, be minor and generally self-limiting, or involve an allowed test that guides care. Pharmacists can order and review medicine-related lab tests, including tests for opioid use disorder treatment. Supervised pharmacy interns or nationally certified pharmacy technicians can perform delegated tests. Independently prescribing pharmacists must follow Board rules for recording care and communicating with primary care providers. These rules must also address patients without a provider or the provider’s contact information. Implementation cannot begin until both one year after enactment and Board notice that final implementing rules are in place.

Pharmacists can prescribe opioid addiction treatment

The law lets licensed Delaware pharmacists with independent prescribing authority prescribe FDA-approved medicines for opioid use disorder. This includes controlled medicines, an exception to the general ban on pharmacist prescribing of controlled substances. Pharmacists must act under a standing order from the Delaware Division of Public Health. Implementation cannot begin until both one year after enactment and Board notice that final implementing rules are in place.

Sponsors & Cosponsors

Sponsor

  • Marie Pinkney

    Democratic • Senate

Cosponsors

  • Eric Buckson

    Republican • Senate

  • Kyra L. Hoffner

    Democratic • Senate

  • Kendra Johnson

    Democratic • House

  • Spiros Mantzavinos

    Democratic • Senate

  • Melissa Minor-Brown

    Democratic • House

  • Eric Morrison

    Democratic • House

  • Nicole Poore

    Democratic • Senate

  • Ray Seigfried

    Democratic • Senate

  • Claire Snyder-Hall

    Democratic • House

Roll Call Votes

All Roll Calls

Yes: 46 • No: 12

House vote • 6/25/2026

Passed (SM required)

Yes: 27 • No: 12

Senate vote • 6/11/2026

Passed (SM required)

Yes: 19 • No: 0

Actions Timeline

  1. Signed by Governor

    7/29/2026Governor

  2. Passed By House. Votes: 27 YES 12 NO 2 ABSENT

    6/25/2026House

  3. Reported Out of Committee (Health & Human Development) in House with 10 On Its Merits

    6/17/2026House

  4. Assigned to Health & Human Development Committee in House

    6/11/2026House

  5. Passed By Senate. Votes: 19 YES 2 ABSENT

    6/11/2026Senate

  6. Amendment SA 2 to SB 320 - Passed By Senate. Votes: 20 YES 1 ABSENT

    6/11/2026Senate

  7. Amendment SA 1 to SB 320 - Stricken in Senate

    6/11/2026Senate

  8. Reported Out of Committee (Health & Social Services) in Senate with 2 Favorable, 3 On Its Merits

    6/10/2026Senate

  9. Amendment SA 2 to SB 320 - Introduced and Placed With Bill

    6/8/2026Senate

  10. Amendment SA 1 to SB 320 - Introduced and Placed With Bill

    6/4/2026Senate

  11. Introduced and Assigned to Health & Social Services Committee in Senate

    5/14/2026Senate

Bill Text

  • Current

    5/14/2026

    HTML

Related Bills

Back to State Legislation